Drug developer Pfizer Inc. said Wednesday a Spanish court upheld its patent covering the active ingredient in the blockbuster cholesterol drug Lipitor, though it did find a second patent for the drug invalid. The company is facing a generic challenge by drug maker Ranbaxy. Pfizer sells Lipitor in Spain under the names Zarator and Cardyl.
July 26, 2007 at 12:00 AM
1 minute read
The original version of this story was published on National Law Journal
Drug developer Pfizer Inc. said Wednesday a Spanish court upheld its patent covering the active ingredient in the blockbuster cholesterol drug Lipitor, though it did find a second patent for the drug invalid.
The company is facing a generic challenge by drug maker Ranbaxy. Pfizer sells Lipitor in Spain under the names Zarator and Cardyl.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
